Select Medical (NYSE:SEM) Stock Rating Lowered by Benchmark

Select Medical (NYSE:SEM) was downgraded by research analysts at Benchmark from a “buy” rating to a “hold” rating in a research note issued to investors on Monday, Marketbeat Ratings reports.

Several other brokerages have also recently issued reports on SEM. StockNews.com cut shares of Select Medical from a “buy” rating to a “hold” rating in a research note on Thursday, November 21st. Royal Bank of Canada increased their price target on shares of Select Medical from $40.00 to $47.00 and gave the company an “outperform” rating in a research note on Monday, November 4th. Finally, Bank of America started coverage on shares of Select Medical in a research note on Tuesday, August 20th. They issued a “buy” rating and a $42.00 price target for the company. Three analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to MarketBeat, Select Medical presently has a consensus rating of “Hold” and an average target price of $40.75.

Select Medical Stock Down 44.9 %

SEM opened at $21.32 on Monday. Select Medical has a twelve month low of $20.17 and a twelve month high of $40.98. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 1.37. The company has a 50-day moving average price of $35.26 and a 200 day moving average price of $35.09. The company has a market cap of $2.76 billion, a PE ratio of 9.97, a price-to-earnings-growth ratio of 1.78 and a beta of 1.42.

Select Medical (NYSE:SEM) last released its quarterly earnings results on Thursday, October 31st. The health services provider reported $0.43 earnings per share for the quarter, topping the consensus estimate of $0.36 by $0.07. Select Medical had a net margin of 3.97% and a return on equity of 15.99%. The firm had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.74 billion. During the same quarter in the prior year, the firm earned $0.46 EPS. The company’s revenue for the quarter was up 5.7% on a year-over-year basis. Sell-side analysts expect that Select Medical will post 2.16 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Select Medical

A number of hedge funds have recently made changes to their positions in the stock. GAMMA Investing LLC boosted its position in shares of Select Medical by 16.6% during the 3rd quarter. GAMMA Investing LLC now owns 2,313 shares of the health services provider’s stock worth $81,000 after purchasing an additional 330 shares during the period. Foster & Motley Inc. boosted its position in shares of Select Medical by 3.1% during the 2nd quarter. Foster & Motley Inc. now owns 12,147 shares of the health services provider’s stock worth $426,000 after purchasing an additional 370 shares during the period. KBC Group NV boosted its position in shares of Select Medical by 4.5% during the 3rd quarter. KBC Group NV now owns 13,050 shares of the health services provider’s stock worth $455,000 after purchasing an additional 563 shares during the period. Arizona State Retirement System boosted its position in shares of Select Medical by 2.0% during the 2nd quarter. Arizona State Retirement System now owns 30,544 shares of the health services provider’s stock worth $1,071,000 after purchasing an additional 593 shares during the period. Finally, Hexagon Capital Partners LLC lifted its holdings in Select Medical by 528.7% during the 2nd quarter. Hexagon Capital Partners LLC now owns 767 shares of the health services provider’s stock worth $27,000 after buying an additional 645 shares in the last quarter. Hedge funds and other institutional investors own 89.48% of the company’s stock.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.